Icosavax - Ownership and Business Overview

Life ScienceCompany

Icosavax Ownership

Who owns Icosavax?

Icosavax is owned by AstraZeneca. It was acquired on December 12, 2023.

Was Icosavax formerly PE-backed?

Yes. Icosavax was formerly owned by 1 private investor.

Icosavax Business Overview

Where is Icosavax headquartered?

Icosavax is headquartered in Seattle, Washington.

What sector is Icosavax in?

Icosavax is a life science company.

When was Icosavax founded?

Icosavax was founded in 2017.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 206 acquisitions of life science companies in 2023, including 27 acquisitions by private equity firms, and 179 by strategics.

Icosavax

Icosavax, Inc.

1930 Boren Ave, Suite 1000,
Seattle, Washington 98101
United States,
(206) 737-0085
www.icosavax.com

Icosavax is a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Icosavax was founded in 2017 and is based in Seattle, Washington.


 Subscribe to unlock this and 208,602
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.